FDA calendar and trial changes: week to 15 October 2026
Week to 15 Oct 2026: 12 clinical trial record changes on ClinicalTrials.gov. Every item links to its source.
Trial record changes this week
Primary completion date changed
Before: Aug 2026. After: 15 Aug 2026.
Recruitment status changed
Before: Recruiting. After: Completed.
Participant count type changed
Before: Estimated. After: Actual.
Completion date type changed
Before: Estimated. After: Actual.
NCT06851559 · Phathom Pharmaceuticals, Inc. (PHAT)
Primary completion date changed
Before: Oct 2026. After: 11 Sep 2026.
Completion date type changed
Before: Estimated. After: Actual.
Primary completion date changed
Before: 30 Dec 2027. After: 4 Nov 2028.
Main study measure wording changed
Compare the two versions on the trial page.
NCT06775379 · Xenon Pharmaceuticals Inc. (XENE)
Primary completion date changed
Before: Aug 2026. After: Oct 2026.
Recruitment status changed
Before: Recruiting. After: Active not recruiting.
NCT05416307 · Electra Therapeutics Inc. (ETRA)
Primary completion date changed
Before: Jun 2027. After: Mar 2028.
NCT06910358 · Disc Medicine, Inc (IRON)
Primary completion date changed
Before: Sep 2026. After: 8 Sep 2026.
Recruitment status changed
Before: Active not recruiting. After: Completed.
Completion date type changed
Before: Estimated. After: Actual.
NCT05139316 · Ultragenyx Pharmaceutical Inc (RARE)
Actual enrollment increased by 3 participants
Before: 49 participants (actual). After: 52 participants (actual).
Main study measure wording changed
Compare the two versions on the trial page.
NCT03762850 · Travere Therapeutics, Inc. (TVTX)
Recruitment status changed
Before: Active not recruiting. After: Completed.
NCT07172516 · Xenon Pharmaceuticals Inc. (XENE)
Recruitment status changed
Before: Recruiting. After: Active not recruiting.
NCT07217860 · Xenon Pharmaceuticals Inc. (XENE)
Recruitment status changed
Before: Enrolling by invitation. After: Active not recruiting.
NCT06922110 · Xenon Pharmaceuticals Inc. (XENE)
Recruitment status changed
Before: Enrolling by invitation. After: Active not recruiting.
NCT07644559 · Verastem, Inc. (VSTM)
Planned enrollment increased by 5 participants
Before: 180 participants (planned). After: 185 participants (planned).